Clinical, neuroimaging, and molecular spectrum of TECPR2-associated hereditary sensory and autonomic neuropathy with intellectual disability
- PMID: 33847017
- DOI: 10.1002/humu.24206
Clinical, neuroimaging, and molecular spectrum of TECPR2-associated hereditary sensory and autonomic neuropathy with intellectual disability
Abstract
Bi-allelic TECPR2 variants have been associated with a complex syndrome with features of both a neurodevelopmental and neurodegenerative disorder. Here, we provide a comprehensive clinical description and variant interpretation framework for this genetic locus. Through international collaboration, we identified 17 individuals from 15 families with bi-allelic TECPR2-variants. We systemically reviewed clinical and molecular data from this cohort and 11 cases previously reported. Phenotypes were standardized using Human Phenotype Ontology terms. A cross-sectional analysis revealed global developmental delay/intellectual disability, muscular hypotonia, ataxia, hyporeflexia, respiratory infections, and central/nocturnal hypopnea as core manifestations. A review of brain magnetic resonance imaging scans demonstrated a thin corpus callosum in 52%. We evaluated 17 distinct variants. Missense variants in TECPR2 are predominantly located in the N- and C-terminal regions containing β-propeller repeats. Despite constituting nearly half of disease-associated TECPR2 variants, classifying missense variants as (likely) pathogenic according to ACMG criteria remains challenging. We estimate a pathogenic variant carrier frequency of 1/1221 in the general and 1/155 in the Jewish Ashkenazi populations. Based on clinical, neuroimaging, and genetic data, we provide recommendations for variant reporting, clinical assessment, and surveillance/treatment of individuals with TECPR2-associated disorder. This sets the stage for future prospective natural history studies.
Keywords: Human Phenotype Ontology; TECPR2; neurodevelopmental disorder; sensory autonomic neuropathy; spastic paraplegia.
© 2021 The Authors. Human Mutation published by Wiley Periodicals LLC.
References
REFERENCES
-
- Anazi, S., Maddirevula, S., Salpietro, V., Asi, Y. T., Alsahli, S., Alhashem, A., Shamseldin, AlZahrani, F., Patel, N., Ibrahim, N., Abdulwahab, F. M., Hashem, M., Alhashmi, N., Al Murshedi, F., Al Kindy, A., Alshaer, A., Rumayyan, A., Al Tala, S., Kurdi, W., … Alkuraya, F. S., & H. E. (2017). Expanding the genetic heterogeneity of intellectual disability. Human Genetics, 136(11), 1419-1429. https://doi.org/10.1007/s00439-017-1843-2
-
- Behrends, C., Sowa, M. E., Gygi, S. P., & Harper, J. W. (2010). Network organization of the human autophagy system. Nature, 466(7302), 68-76. https://doi.org/10.1038/nature09204
-
- Cingolani, P., Patel, V. M., Coon, M., Nguyen, T., Land, S. J., Ruden, D. M., & Lu, X. (2012). Using Drosophila melanogaster as a model for genotoxic chemical mutational studies with a new program, SnpSift. Frontiers in Genetics, 3, 35. https://doi.org/10.3389/fgene.2012.00035
-
- Cingolani, P., Platts, A., Wang, L. L., Coon, M., Nguyen, T., Wang, L., Land, S. J., Lu, X., & Ruden, D. M. (2012). A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: Snps in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly, 6(2), 80-92. https://doi.org/10.4161/fly.19695
-
- Covone, A. E., Fiorillo, C., Acquaviva, M., Trucco, F., Morana, G., Ravazzolo, R., & Minetti, C. (2016). Wes in a family trio suggests involvement of TECPR2 in a complex form of progressive motor neuron disease: Wes in a family trio suggests involvement of TECPR2. Clinical Genetics, 90(2), 182-185. https://doi.org/10.1111/cge.12730
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
